Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 millionInvivyd in vitro data showed continued neutrali ...
Intero Digital reports that the real estate search landscape is shifting to AI, requiring agents to build a local authority ...